Unclassified

Consumer Product Recall: Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs

Kramer Laboratories, of Bridgewater, New Jersey (a subsidiary of Arcadia Consumer Healthcare, of Bridgewater, New Jersey) · April 10, 2025

Reason for Recall

The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.

Product Description

This recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. They are labeled with "Safetussin," "Multi-Symptom," "Cough, Cold & Flu" and "Safe for adults with High Blood Pressure, Diabetes." They were sold in a blue, orange and red cardboard box with the drug facts label on the back.

Quantity Affected

About 14,250

Source: Consumer Product Safety Commission

Recall number: 25223

Status: ongoing

View original recall notice at Consumer Product Safety Commission →

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.

Kramer Laboratories, of Bridgewater, New Jersey (a subsidiary of Arcadia Consumer Healthcare, of Bridgewater, New Jersey) Consumer Product Recall: Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs | SafeCheck